It was one of Canada’s hottest restaurants, lauded by food critics, winner of multiple awards, and featured on the Food Network — until somebody noticed the cockroaches. Tres Carnales, a trendy ...

The first weekend of October marked the official halfway point of the 2025 Rhode Island high school football season and the games didn’t disappoint. Big rivalries ruled the weekend but there were ...

It’s certainly getting interesting in all four divisions with the girls soccer races flipping to October. La Salle and North Kingstown are battling for the top seed in Division I, but Mt. Hope and ...

Update- PATH service between Newark and World Trade Center and Journal Square and 33rd Street WK-has resumed with delays. NJ Transit is cross-honoring PATH passengers at Newark. A person was hit by a ...

With early voting set to begin in just over a week, Albuquerque Mayor Tim Keller has a solid lead in his bid for an unprecedented third straight term, a new Journal Poll found. The survey of proven ...

Four Edmonton Starbucks locations served their final caramel macchiatos Saturday. As part of the global coffee chain’s restructuring plan, four Edmonton cafes closed Saturday. Staff at these locations ...

The BMJ Group has retracted a study that was published last year about apple cider vinegar and weight loss. The study, which received widespread media attention at the time, claimed drinking diluted ...

Sept. 23 (UPI) --The Wall Street Journal filed a motion Monday to dismiss President Donald Trump's $10 billion defamation lawsuit over the newspaper's reporting on a 50th birthday letter he claims he ...

Lawyers for The Wall Street Journal blasted Donald Trump’s defamation lawsuit against the publishers and journalists who uncovered his alleged birthday letter to convicted sex offender Jeffrey Epstein ...

NEW YORK, Sept 22 (Reuters) - The Wall Street Journal asked a U.S. judge on Monday to dismiss President Donald Trump's lawsuit alleging the paper defamed him in a July 17 article asserting Trump's ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The program, now in its 22nd ...

US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Stage II and III ...